Prediction of Behavioral Improvement Through Resting-State Electroencephalography and Clinical Severity in a Randomized Controlled Trial Testing Bumetanide in Autism Spectrum DisorderBIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGINGIF4.82023-03-0126OAAI
Bumetanide Effects on Resting-State EEG in Tuberous Sclerosis Complex in Relation to Clinical Outcome: An Open-Label StudyFRONTIERS IN NEUROSCIENCEIF3.22022-05-124OAAI
Measurement of excitation-inhibition ratio in autism spectrum disorder using critical brain dynamicsSCIENTIFIC REPORTSIF3.92020-06-08120OAAI
Non-Invasive Estimation of Excitation-Inhibition Balance Facilitates Physiological Dissection of Autism Spectrum DisorderBIOLOGICAL PSYCHIATRYIF92019-05-010PREAI
Behavioural and Neurophysiological Outcomes of the Bumetanide in Autism Medication and Biomarker (BAMBI) TrialBIOLOGICAL PSYCHIATRYIF92019-05-010PREAI
Virtual localization of the seizure onset zone: Using non-invasive MEG virtual electrodes at stereo-EEG electrode locations in refractory epilepsy patientsNEUROIMAGE-CLINICALIF3.62018-01-0121OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向